200 related articles for article (PubMed ID: 29463786)
21. The histone demethylase PHF8 is an oncogenic protein in human non-small cell lung cancer.
Shen Y; Pan X; Zhao H
Biochem Biophys Res Commun; 2014 Aug; 451(1):119-25. PubMed ID: 25065740
[TBL] [Abstract][Full Text] [Related]
22. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
23. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of SRPK1 in non-small cell lung cancer promotes the growth and migration of cancer cells.
Liu H; Hu X; Zhu Y; Jiang G; Chen S
Tumour Biol; 2016 Jun; 37(6):7287-93. PubMed ID: 26666824
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of LINC01510 predicts poor prognosis and promotes malignant progression in human non-small cell lung cancer.
Li J; Wei L
Biomed Pharmacother; 2019 Jan; 109():519-529. PubMed ID: 30399588
[TBL] [Abstract][Full Text] [Related]
27. Cyclovirobuxine D inhibits growth and progression of non‑small cell lung cancer cells by suppressing the KIF11‑CDC25C‑CDK1‑CyclinB1 G
Xue T; Chen Y; Xu J; Du W; Kong P; Zhang X
Int J Oncol; 2023 May; 62(5):. PubMed ID: 36929198
[TBL] [Abstract][Full Text] [Related]
28. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
Mao M; Wu Z; Chen J
Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
[TBL] [Abstract][Full Text] [Related]
30. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
[TBL] [Abstract][Full Text] [Related]
31. Growth arrest and apoptosis via caspase activation of dioscoreanone in human non-small-cell lung cancer A549 cells.
Hansakul P; Aree K; Tanuchit S; Itharat A
BMC Complement Altern Med; 2014 Oct; 14():413. PubMed ID: 25342427
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
33. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
Li X; Wan L; Geng J; Wu CL; Bai X
J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249
[TBL] [Abstract][Full Text] [Related]
34. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
35. GRK5 promotes tumor progression in renal cell carcinoma.
Zhao TL; Gan XX; Bao Y; Wang WP; Liu B; Wang LH
Neoplasma; 2019 Feb; 66(2):261-270. PubMed ID: 30784280
[TBL] [Abstract][Full Text] [Related]
36. MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer.
Sun L; Yuan H; Burnett J; Gasparyan M; Zhang Y; Zhang F; Yang Z; Ran Y; Sun D
Int J Med Sci; 2019; 16(1):68-74. PubMed ID: 30662330
[No Abstract] [Full Text] [Related]
37. FOXA1 prolongs S phase and promotes cancer progression in non-small cell lung cancer through upregulation of CDC5L and activation of the ERK1/2 and JAK2 pathways.
Chen G; Wei RS; Ma J; Li XH; Feng L; Yu JR
Kaohsiung J Med Sci; 2023 Nov; 39(11):1077-1086. PubMed ID: 37658700
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancer.
Lin Z; Xiong L; Lin Q
Med Oncol; 2015 Jul; 32(7):183. PubMed ID: 26008152
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing β-catenin expression.
Liu J; Tian W; Zhang W; Jia Y; Yang X; Wang Y; Zhang J
Biomed Pharmacother; 2019 Jun; 114():108847. PubMed ID: 30970294
[TBL] [Abstract][Full Text] [Related]
40. ETS-1 Induces Endothelial-Like Differentiation and Promotes Metastasis in Non-Small Cell Lung Cancer.
Zhou X; Zhou R; Zhou H; Li Q; Hong J; Meng R; Zhu F; Zhang S; Dai X; Peng G; Wu G; Li Z
Cell Physiol Biochem; 2018; 45(5):1827-1839. PubMed ID: 29510376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
